The role of diabetes co-morbidity for tuberculosis treatment outcomes: a prospective cohort study from Mwanza, Tanzania

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Faurholt Jepsen, Daniel ^a   Range, Nyagosya ^b   Praygod, George ^b   Kidola, Jeremiah ^b   Faurholt Jepsen, Maria ^a   Aabye, Martine G ^a   Changalucha, John ^b   Christensen, Dirk L ^a,c   Martinussen, Torben ^a   Krarup, Henrik ^d   Witte, Daniel R ^c   Andersen, Åse B ^e   Friis, Henrik ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NATIONAL INSTITUTE OF MEDICAL RESEARCH   (Tanzania)

^c STENO DIABETES CENTER   (Denmark)

^d AALBORG UNIVERSITY HOSPITAL   (Denmark)

^e ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Anthropometry; Diabetes; Grip strength; Haemoglobin; Treatment outcome; Tuberculosis

Indexed keywords

HEMOGLOBIN; TUBERCULOSTATIC AGENT;

ADULT; ARM CIRCUMFERENCE; ARTICLE; BODY MASS; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; GRIP STRENGTH; HUMAN; LEUKOCYTE COUNT; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PROSPECTIVE STUDY; SKINFOLD THICKNESS; TANZANIA; TREATMENT OUTCOME; WAIST CIRCUMFERENCE; WEIGHT GAIN;

ADULT; BODY MASS INDEX; COHORT STUDIES; DIABETES COMPLICATIONS; FEMALE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TANZANIA; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

EID: 84864260066     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-165     Document Type: Article

References (29)

1. Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 2008, 5:e152. 10.1371/journal.pmed.0050152, 2459204, 18630984.
2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053. 10.2337/diacare.27.5.1047, 15111519.
3. Güler M, Ünsal E, Dursun B, AydIn T, Capan N. Factors influencing sputum smear and culture conversion time among patients with new case pulmonary tuberculosis. Int J Clin Pract 2007, 61:231-235.
4. Dooley KE, Tang T, Golub JE, Dorman SE, Cronin W. Impact of Diabetes Mellitus on Treatment Outcomes of Patients with Active Tuberculosis. AmJTrop Med Hyg 2009, 80:634-639.
5. Wang CS, Yang CJ, Chen HC, Chuang SH, Chong IW, Hwang JJ, Huang MS. Impact of type 2 diabetes on manifestations and treatment outcome of pulmonary tuberculosis. Epidemiol Infect 2009, 137:203-210. 10.1017/S0950268808000782, 18559125.
6. Sasaki Y, Yamagishi F, Yagi T, Itakura M, Fujikawa A, Kuga M, Ishimaru T. A study on pulmonary tuberculosis retreatment cases. Kekkaku 2003, 78:723-732.
7. PrayGod G, Range N, Faurholt-Jepsen D, Jeremiah K, Faurholt-Jepsen M, Aabye MG, Jensen L, Jensen AV, Grewal HMS, Magnussen P, Changalucha J, Andersen AB, Friis H. Weight, body composition and handgrip strength among pulmonary tuberculosis patients: a matched cross-sectional study in Mwanza, Tanzania. Trans. R. Soc. Trop. Med. Hyg 2011, 105:140-147. 10.1016/j.trstmh.2010.11.009, 21239027.
8. Dulloo AG, Jacquet J, Montani J-P. Pathways from weight fluctuations to metabolic diseases: focus on maladaptive thermogenesis during catch-up fat. Int. J. Obes. Relat. Metab. Disord. 2002, 26(2):46-57.
9. Walter T, Olivares M, Pizarro F, Muñoz C. Iron, Anemia, and Infection. Nutr Rev 1997, 55:111-124.
10. PrayGod G, Range N, Faurholt-Jepsen D, Jeremiah K, Faurholt-Jepsen M, Aabye MG, Jensen L, Jensen AV, Grewal HMS, Magnussen P, Changalucha J, Andersen AB, Friis H. Daily Multi-Micronutrient Supplementation during Tuberculosis Treatment Increases Weight and Grip Strength among HIV-Uninfected but Not HIV-Infected Patients in Mwanza, Tanzania. J Nutr 2011, 141:685-691. 10.3945/jn.110.131672, 21346105.
11. Global tuberculosis control: a short update to the 2009 report http://www.who.int/tb/publications/global_report/2009/update/en/index.html.
12. Whiting DR, Guariguata L, Weil C, Shaw J. IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Research and Clinical Practice 2011, 94:311-321. 10.1016/j.diabres.2011.10.029, 22079683.
13. Chonde TM, Basra D, Mfinanga SGM, Range N, Lwilla F, Shirima RP, van Deun A, Zignol M, Cobelens FG, Egwaga SM, van Leth F. National anti-tuberculosis drug resistance study in Tanzania. Int. J. Tuberc. Lung Dis. 2010, 14:967-972.
14. Range N, Magnussen P, Mugomela A, Malenganisho W, Changalucha J, Temu MM, Mngara J, Krarup H, Friis H, Andersen T. HIV and parasitic co-infections in tuberculosis patients: a cross-sectional study in Mwanza, Tanzania. Ann Trop Med Parasitol 2007, 101:343-351. 10.1179/136485907X176373, 17524249.
15. Faurholt-Jepsen D, Range N, Praygod G, Jeremiah K, Faurholt-Jepsen M, Aabye MG, Changalucha J, Christensen DL, Pipper CB, Krarup H, Witte DR, Andersen AB, Friis H. Diabetes is a risk factor for pulmonary tuberculosis: a case-control study from mwanza. Tanzania. PLoS ONE 2011, 6:e24215.
16. Faurholt-Jepsen D, Range N, PrayGod G, Jeremiah K, Faurholt-Jepsen M, Aabye MG, Changalucha J, Christensen DL, Krarup H, Witte DR, Andersen AB, Friis H. The role of diabetes on the clinical manifestations of pulmonary tuberculosis. Tropical Medicine & International Health 2012, 17:877-883. 10.1111/j.1365-3156.2012.03002.x, 23007705.
17. Treatment of Tuberculosis: guidelines for national programmes http://www.who.int/tb/publications/tb_treatmentguidelines/en/index.html.
18. Praygod G, Range N, Faurholt-Jepsen D, Jeremiah K, Faurholt-Jepsen M, Aabye MG, Jensen L, Jensen AV, Grewal HMS, Magnussen P, Changalucha J, Andersen AB, Friis H. The effect of energy-protein supplementation on weight, body composition and handgrip strength among pulmonary tuberculosis HIV-co-infected patients: randomised controlled trial in Mwanza, Tanzania. Br J Nutr 2012, 107:1-9. 10.1017/S0007114511003400, 21787448.
19. IUATLD Technical guide: sputum examination for tuberculosis by direct microscopy in low income countries 2000, Paris: 5th edition. International Union Against Tuberculosis and Lung Disease (IUATLD), IUATLD.
20. Frisancho AR. Anthropometric standards for the assessment of growth and nutritional status 1990, Ann Arbor: The University of Michigan Press.
21. Gearhart MM, Parbhoo SK. Hyperglycemia in the critically ill patient. AACN Clin Issues 2006, 17:50-55. 10.1097/00044067-200601000-00007, 16462409.
22. Başoǧlu OK, Bacakoǧlu F, Cok G, Sayiner A, Ateş M. The oral glucose tolerance test in patients with respiratory infections. Monaldi Arch Chest Dis 1999, 54:307-310.
23. WHO Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia 2006, Geneva, Switzerland: WHO Press, WHO.
24. Fitzmaurice GM, Laird NM, Ware JH. Applied Longitudinal Analysis 2011, Hoboken, New Jersey: Wiley, 2.
25. Kreuzer K-A, Rockstroh JK. Pathogenesis and pathophysiology of anemia in HIV infection. Ann Hematol 1997, 75:179-187. 10.1007/s002770050340, 9433373.
26. Collins S, Myatt M, Golden B. Dietary treatment of severe malnutrition in adults. Am J Clin Nutr 1998, 68:193-199.
27. Marchesini G, Forlani G, Zoli M, Vannini P, Pisi E. Muscle protein breakdown in uncontrolled diabetes as assessed by urinary 3-methylhistidine excretion. Diabetologia 1982, 23:456-458.
28. Nair G, Sainani GS, Krishnaswamy PR. Evidence of glycosylation of platelet proteins in diabetics. J Assoc Physicians India 1985, 33:299-300.
29. Andersen AB, Range NS, Changalucha J, PrayGod G, Kidola J, Faurholt-Jepsen D, Krarup H, Grewal H, Friis H. CD4 lymphocyte dynamics in Tanzanian pulmonary tuberculosis patients with and without HIV co-infection. BMC Infect Dis 2012, 12:66. 10.1186/1471-2334-12-66, 3383481, 22436147.